Frontlight ResearchEarly access
Peripheral artery disease trials in Iran
1 trial · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleCoated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease
- Where
- Tehran
- Age
- 18 years and over
- People
- 3,000
- Run by
- Rajaie Cardiovascular Medical and Research Center
See details and how to joinNCT06541691